lunes, 30 de octubre de 2017

FDA Law Blog: FDLI’s Drug Quality Security Act Conference

FDA Law Blog: FDLI’s Drug Quality Security Act Conference

Posted: 22 Oct 2017 06:52 PM PDT
The Food and Drug Law Institute’s (“FDLI”) Drug Quality and Security Act (“DQSA”) conference is just a few weeks away, and spaces are going fast! The conference will be held on November 15, 2017, in Washington, D.C. Hyman, Phelps & McNamara, P.C.’s Karla L. Palmer will be chairing the conference.

Panels of key government regulators and industry experts will explore current issues surrounding the DQSA’s Title I (Compounding Quality Act) and Title II (Drug Supply Chain Security Act) four years after implementation. Title I has had a significant impact in compounding pharmaceutical products by outsourcing facilities and traditional pharmacies. Conference speakers will review the changes in the lawFDA’s current guidance, regulatory responses, and related state actions involving compounding. Title II has and will continue to have a significant impact on drug manufacturers, wholesalers and pharmacies, especially as they implement the next phases of the Drug Supply Chain Security Act and await additional FDA guidance.

You can learn more about and register for the conference here.  Use discount code “DQSA-Save10” to save 10% off the registration fee.

No hay comentarios: